GastroEsophageal Cancer New Reference: Nivolumab and Ipilimumab for Advanced Gastric Cancer Ulas D. Bayraktar, MD 2025-09-08
Chronic Lymphocytic Leukemia New Reference: Pirtobrutinib for BTKi Pretreated CLL Ulas D. Bayraktar, MD 2025-09-08
Acute myeloid leukemia New Protocol: Revumenib with Azacitidine and Venetoclax for KMT2-Rearranged / NPM1-Mutated Ulas D. Bayraktar, MD 2025-09-08
Diffuse Large B Cell Lymphoma New Protocol: Glofitamab with R-CHOP for High-Risk DLBCL Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Indication: Neoadjuvant Osimertinib with/without Chemo for NSCLC Ulas D. Bayraktar, MD 2025-09-08
Nasopharyngeal Cancer New Drug: Penpulimab with Platinum – Gemcitabine in Advanced Nasopharyngeal Carcinoma Ulas D. Bayraktar, MD 2025-06-09
Non-Small Cell Lung Cancer New Drug: Telisotuzumab vedotin for cMET Amplified NSCLC Ulas D. Bayraktar, MD 2025-06-09
Non-Small Cell Lung Cancer New Reference: Maintenance Atezolizumab for Stage IB-IIIA NSCLC Ulas D. Bayraktar, MD 2025-06-02
Chronic Lymphocytic Leukemia New Protocol: Zanubrutinib with Venetoclax for Untreated CLL Ulas D. Bayraktar, MD 2025-06-02
